Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Nitrofurantoin

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44364   clinical trials with a EudraCT protocol, of which   7388   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    21 result(s) found for: Nitrofurantoin. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2013-004174-10 Sponsor Protocol Number: P1351 Start Date*: 2013-11-18
    Sponsor Name:UMC St Radboud
    Full Title: Pharmacokinetics of nitrofurantoin in the elderly
    Medical condition: Uncomplicated urinary tract infection
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-004297-14 Sponsor Protocol Number: SLH2015001 Start Date*: 2016-06-08
    Sponsor Name:Streeklaboratorium voor de volksgezondheid Kennemerland
    Full Title: Effectiveness of fosfomycin versus nitrofurantoin in Dutch risk groups with cystitis: a pilot study (Uri-weg study)
    Medical condition: Cystitis without tissue invasion (uncomplicated cytitis)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-000553-27 Sponsor Protocol Number: 212390 Start Date*: 2020-06-24
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin...
    Medical condition: Urinary Tract Infection (Acute Cystitis)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: BG (Completed) PL (Completed)
    Trial results: View results
    EudraCT Number: 2007-003398-24 Sponsor Protocol Number: OAB/AB/07 Start Date*: 2008-01-21
    Sponsor Name:The Whittington Hospital NHS Trust
    Full Title: A randomised, double blind validation of the significance of occult pyuria for the symptoms of the overactive bladder
    Medical condition: The overactive bladder
    Disease: Version SOC Term Classification Code Term Level
    9.1 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-017939-18 Sponsor Protocol Number: 08/0316 Start Date*: 2010-12-15
    Sponsor Name:University College London
    Full Title: A Phase 4 randomised, double-blind, placebo controlled, crossover trial Nitrofurantoin Macrocrystals 100 mg twice daily for six weeks in the treatment of overactive bladder symptoms associated w...
    Medical condition: Chronic urinary tract infection.
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004857 10059617 Overactive bladder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2011-000129-61 Sponsor Protocol Number: ASB-treat-study Start Date*: 2011-11-14
    Sponsor Name:AMC Amsterdam
    Full Title: ASB treat study: Preventing preterm birth with nitrofurantoin: Costs and effects of screening and treating healthy women for asymptomatic bacteriuria’
    Medical condition: Preterm birth<34wks and pyelonefritis in singleton healthy pregnancies
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036600 LLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-001801-98 Sponsor Protocol Number: 204989 Start Date*: 2020-02-27
    Sponsor Name:GlaxoSmithKline Research & Development Limited
    Full Title: A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin...
    Medical condition: Urinary Tract Infection (Acute Cystitis)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10011781 Cystitis PT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) BG (Completed) GR (Completed) HU (Completed) CZ (Completed) SK (Completed) RO (Ongoing)
    Trial results: View results
    EudraCT Number: 2020-005559-19 Sponsor Protocol Number: FUR-03-17 Start Date*: 2021-02-23
    Sponsor Name:ADAMED Pharma S.A.
    Full Title: FRUTI - a phase III, randomized, multicenter, double-blind, active control study to evaluate the efficacy and safety of Furazidin prolonged-release tablets, 200 mg compared with Nitrofurantoin prol...
    Medical condition: uncomplicated lower urinary tract infections (acute or recurrent)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10046577 Urinary tract infections HLT
    20.0 10021881 - Infections and infestations 10046571 Urinary tract infection PT
    20.0 10021881 - Infections and infestations 10024981 Lower urinary tract infection LLT
    20.0 10021881 - Infections and infestations 10038140 Recurrent urinary tract infection LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Female
    Trial protocol: PL (Completed) HU (Completed) DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000309-21 Sponsor Protocol Number: PREDICT_Trial_Amd_04 Start Date*: 2013-10-01
    Sponsor Name:Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Full Title: Antibiotic Prophylaxis and Renal Damage In Congenital abnormalities of the kidney and urinary Tract
    Medical condition: Infants with vesicoureteral reflux grade III-V, started before the first symptomatic infection.
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004857 10047371 Vesicoureteral reflux LLT
    Population Age: Infants and toddlers, Under 18 Gender: Male, Female
    Trial protocol: IT (Completed) LT (Completed) ES (Ongoing) DE (Ongoing) SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-003704-31 Sponsor Protocol Number: ARG-16 Start Date*: 2019-05-17
    Sponsor Name:Uppsala University
    Full Title: Impact on the intestinal microbiota during antibiotic treatment
    Medical condition: Impact on the intestinal microbiota during antibiotic treatment
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-004586-17 Sponsor Protocol Number: UV 2007/01 Start Date*: 2008-04-04
    Sponsor Name:OM PHARMA
    Full Title: Multicentre, double-blind, placebo controlled randomised clinical study of URO-VAXOM® in female patients suffering from uncomplicated recurrent urinary tract infections
    Medical condition: Uncomplicated recurrent urinary tract infections
    Disease: Version SOC Term Classification Code Term Level
    9.1 10038140 Recurrent urinary tract infection LLT
    Population Age: Elderly Gender: Female
    Trial protocol: DE (Completed) AT (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2012-001542-18 Sponsor Protocol Number: AAD-EU2012 Start Date*: 2012-07-12
    Sponsor Name:DuPont Nutrition and Health Active Nutrition
    Full Title: Effect of a probiotic formula on reducing the risk for antibiotic-associated diarrhea
    Medical condition: Antibiotic-associated diarrhea
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004856 10002739 Antibiotic-associated diarrhea LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-003487-36 Sponsor Protocol Number: 1 Start Date*: 2015-12-23
    Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust
    Full Title: Alternatives to prophylactic antibiotics for the treatment of recurrent urinary tract infection in women
    Medical condition: Recurrent urinary tract infection in women
    Disease: Version SOC Term Classification Code Term Level
    18.1 10042613 - Surgical and medical procedures 10064736 Antibiotic prophylaxis PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-002556-32 Sponsor Protocol Number: ANTIC:6672 Start Date*: 2013-09-05
    Sponsor Name:The Newcastle upon Tyne Hospitals NHS Foundation Trust
    Full Title: Antibiotic treatment for intermittent bladder catheterisation: A randomised controlled trial of once daily prophylaxis (The AnTIC study)
    Medical condition: Recurrent urinary tract infection in people who use intermittent bladder catheterisation.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10064736 Antibiotic prophylaxis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2021-001332-26 Sponsor Protocol Number: IJG-SCOUT-2021 Start Date*: 2021-09-06
    Sponsor Name:IDIAP Jordi Gol
    Full Title: Clinical effectiveness and bacteriological eradication of 3 short-course antibiotic regimens and single-dose of fosfomicyn trometamol for lower urinary tract infections in adult women [SCOUT study].
    Medical condition: Uncomplicated Lower urinary tract infections (uLUTI)
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10046544 Urinary infection LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-003282-17 Sponsor Protocol Number: 190801 Start Date*: 2020-02-11
    Sponsor Name:Thomas Benfield
    Full Title: Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study
    Medical condition: Gram-negative bacteremia
    Disease: Version SOC Term Classification Code Term Level
    20.1 10021881 - Infections and infestations 10054228 Gram-negative bacteremia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2014-000180-41 Sponsor Protocol Number: P000176 Start Date*: 2015-04-08
    Sponsor Name:Medical Center - University of Freiburg
    Full Title: Carriage of 3GCREB in patients at risk for relapsing infection: randomized controlled trial of intestinal decolonization with colistin plus rifaximin.
    Medical condition: Intestinal carriage of 3GCREB responsible for relapsing infection
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-003466-12 Sponsor Protocol Number: MCMK0220 Start Date*: 2022-03-25
    Sponsor Name:MCM Klosterfrau Vertriebsgesellschaft mbH
    Full Title: A double-blind, randomised, multi-centre, controlled clinical trial to compare D-mannose versus antibiotic in the treatment of acute uncomplicated lower urinary tract infections in female patients
    Medical condition: acute uncomplicated lower urinary tract infections
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021881 - Infections and infestations 10024981 Lower urinary tract infection LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-002747-14 Sponsor Protocol Number: OF_FUM_CT1 Start Date*: 2021-05-24
    Sponsor Name:"Olainfarm" AS
    Full Title: A multi-center, randomized, double-blind, double-dummy, parallel-group, active drug controlled, adaptive, Phase III study to investigate efficacy, safety and tolerability of Furamag (Furaginum solu...
    Medical condition: Microbiologically confirmed acute uncomplicated lower urinary tract infections in women.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10046577 Urinary tract infections HLT
    Population Age: Adults Gender: Female
    Trial protocol: LT (Prematurely Ended) CZ (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-000338-20 Sponsor Protocol Number: MK-7655A-021 Start Date*: 2019-06-26
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Phase 2/3 Open-label, Randomized, Active-controlled Clinical Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of MK-7655A in Pediatric Participants From Birth to Less Tha...
    Medical condition: Treatment of bacterial infections in pediatric populations
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004862 10071097 Beta-lactam antibiotic resistance LLT
    Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Completed) PL (Completed) Outside EU/EEA ES (Completed) BG (Completed) GR (Completed) NO (Completed) EE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Nov 16 20:05:58 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA